Core Insights - Recently, Shanghai Waigaoqiao Group's subsidiary, Shanghai Waigaoqiao Biomedical Industry Development Co., Ltd., signed a strategic cooperation agreement with Shanghai Meixin Health Technology Group Co., Ltd. [1] - The collaboration aims to leverage each party's resources and strengths to innovate a multi-payment mechanism involving "medical insurance + commercial insurance + corporate co-payment" [1] - The focus is on promoting the implementation and accessibility of innovative drug and medical device payments in real-world scenarios, exploring new models for the synergistic development of commercial insurance and the biomedical industry [1]